Strides Pharma Science Limited: Detailed financials
Line items extracted directly from the company's exchange-filed XBRL. Click + to expand subtotals. Click any row to chart it. Monetary values are in ₹ crore.
Company financials
| Particulars | Dec-24 | Mar-25 | Jun-25 | Sep-25 | Dec-25 | Mar-26 | Jun-26 | Sep-26 |
|---|---|---|---|---|---|---|---|---|
| 1,154 | 1,190 | 1,120 | 1,221 | 1,195 | 1,323 | 1,265 | 1,430 | |
| 6 | 12 | 9 | 27 | 107 | 8 | 5 | 4 | |
| 1,044 | 1,072 | 998 | 1,085 | 1,053 | 1,179 | 1,133 | 1,283 | |
| 477 | 270 | 261 | 430 | 460 | 409 | 415 | 565 | |
| 134 | 232 | 121 | 42 | 71 | 127 | 166 | 181 | |
| −130 | −2 | 63 | 44 | −68 | −0.08 | −86 | −116 | |
| 216 | 223 | 226 | 227 | 230 | 247 | 243 | 238 | |
| 52 | 50 | 47 | 46 | 43 | 42 | 41 | 47 | |
| 48 | 49 | 49 | 50 | 51 | 53 | 56 | 57 | |
| 248 | 251 | 232 | 247 | 266 | 300 | 297 | 311 | |
| 213 | 202 | 218 | 250 | 340 | 241 | 298 | 253 | |
| 165 | 154 | 169 | 200 | 289 | 188 | 241 | 196 | |
| −2 | −27 | −8 | −9 | −3 | −6 | 63 | −2 | |
| 113 | 103 | 122 | 154 | 246 | 147 | 201 | 150 | |
| 24 | 21 | 16 | 22 | 37 | 19 | 34 | 16 | |
| 90 | 86 | 106 | 132 | 208 | 129 | 165 | 134 | |
| Financial ratios | ||||||||
| 18.51% | 17.01% | 19.49% | 20.47% | 28.42% | 18.24% | 23.54% | 17.72% | |
| 7.80% | 7.19% | 9.43% | 10.77% | 17.42% | 9.77% | 13.08% | 9.38% | |
| 9.56 | 8.92 | 10.81 | 13.84 | 21.93 | 13.77 | 17.02 | 14.19 | |
Revenue
₹ crore
Select any table row to compare its reported history.
Source: official NSE or BSE financial-result filings & XBRL. Figures are exact values reported by the issuer at filing time, never estimated. Derived margins, subtotals, leverage and cash-flow measures use only the displayed filed line items.